dipyridamole has been researched along with Blood Poisoning in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coeugniet, E | 1 |
| Harker, LA | 1 |
| Slichter, SJ | 1 |
| Dacie, JV | 1 |
3 other studies available for dipyridamole and Blood Poisoning
| Article | Year |
|---|---|
Letter: Clinical and experimental effects of dipyridamole.
Topics: Anti-Inflammatory Agents; Candida albicans; Dipyridamole; Drug Synergism; Endotoxins; Erythrocyte Ag | 1975 |
Platelet and fibrinogen consumption in man.
Topics: Blood Cell Count; Blood Platelets; Catheterization; Cell Survival; Dipyridamole; Disseminated Intrav | 1972 |
[Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Aspirin; Dextrans; Dipyridamole; Drug Hypersensitivity; | 1973 |